Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
antipsychotic
Pharma
Gilead-backed Lyndra lays off staff as it nears pivotal data
Gilead-backed Lyndra is laying off staff more than two years after raising nearly $61 million and as recruitment continues in a pivotal trial.
Max Bayer
Sep 15, 2023 3:33pm
FDA advisers back Rexulti new use in nearly unanimous vote
Apr 14, 2023 9:24pm
Sanofi offloads rights to prolonged-release antipsychotic drug
Apr 26, 2022 10:18am
Intra-Cellular's Caplyta gains label expansion with bipolar nod
Dec 20, 2021 4:45pm
Amid flurry of settlements, J&J resolves Risperdal claims
Nov 1, 2021 10:45am
Teva launches first DTC for Austedo into competitive market
May 28, 2021 7:20am
